BioSpace - Matrix Laboratories Limited News, Search Jobs, Events

Industry

Segment

Mylan Inc. (MYL) Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories Limited (MAXL.BO) 11/11/2009 8:25:40 AM More...

Mylan Inc. (MYL) to Pay $133 Million for Rest of Matrix Laboratories Limited (MAXL.BO) 3/26/2009 11:36:40 AM More...

Mylan Inc. (MYL)'s Matrix Laboratories Limited (MAXL.BO) Receives World Health Organization Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor 2/25/2009 10:18:08 AM More...

Matrix Laboratories Limited (MAXL.BO) May Sell European Generics Unit Docpharma 2/28/2008 11:13:39 AM More...

Mylan Laboratories Inc. (MYL) Completes Matrix Laboratories Limited (MAXL.BO) Transaction 1/9/2007 10:57:09 AM More...

Mylan Laboratories Inc. (MYL) Announces Closing Of Public Offer To Acquire 20% Of Matrix Laboratories Limited (MAXL.BO) 12/21/2006 11:07:21 AM More...

Gilead Sciences (Foster City, CA) (GILD) Announces Licensing Agreements With Eight India-Based Companies For Manufacturing And Distribution Of Generic Versions Of Viread In The Developing World 9/25/2006 11:36:57 AM More...

The Day In Review: FDA Pays $500 Million For Cancer Drug 8/28/2006 6:02:40 PM More...

Mylan Laboratories Inc. (MYL) To Acquire Matrix Laboratories Limited (MAXL.BO) For Up To $736 Million 8/28/2006 9:19:33 AM More...

Matrix Laboratories Limited (MAXL.BO) Buys 55% Stake In Concord Biotech 12/6/2005 12:25:37 PM More...